Flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group

被引：0
|
作者：
Westers, T. M. [1 ]
Kern, W. [2 ]
Ireland, R. [3 ]
Bene, M. C. [4 ,5 ]
Della Porta, M. G. [6 ]
Ogata, K. [7 ,8 ]
Van de Loosdrecht, A. A. [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Hematol, Amsterdam, Netherlands
[2] Munich Leukemia Lab, Munich, Germany
[3] Kings Coll Hosp London, Haematol, London, England
[4] Univ Nancy, Fac Med, Nancy, France
[5] Univ Nancy, CHU, Nancy, France
[6] Univ Pavia, Fdn IRCCS Policlin San Matteo, Sch Med, Hematol Oncol, I-27100 Pavia, Italy
[7] Nippon Med Sch, Div Hematol, Tokyo 113, Japan
[8] Nippon Med Sch, Dept Med, Tokyo 113, Japan
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70100-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-051
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [31] Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis
    Stetler-Stevenson, M.
    Yuan, C. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2009, 31 (05) : 479 - 483
  • [32] Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
    Della Porta, Matteo G.
    Picone, Cristina
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [33] Identification of prognostic subgroups by flow cytometry in myelodysplastic syndromes
    van de Loosdrecht, A.
    Ossenkoppele, G.
    Westers, T.
    LEUKEMIA RESEARCH, 2009, 33 : S11 - S11
  • [34] Validation of International Working Group (IWG) Response Criteria in Higher-Risk Myelodysplastic Syndromes (MDS): A Report on Behalf of the MDS Clinical Research Consortium (MDS CRC)
    Komrokji, Rami S.
    DeZern, Amy E.
    Zell, Katrina
    Al Ali, Najla H.
    Estling, Christopher
    Zimmerman, Cassie
    Hand, Wesley
    Brown, Francis
    Rizzo, Nicole
    Barnard, John
    Roboz, Gail J.
    Garcia-Manero, Guillermo
    Steensma, David P.
    Sekeres, Mikkael A.
    BLOOD, 2015, 126 (23)
  • [35] IDENTIFICATION OF PROGNOSTIC SUBGROUPS BY FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES
    van de Loosdrecht, A. A.
    Alhan, C.
    Cali, C.
    Draeger, A. M.
    Ossenkoppele, G. J.
    Westers, T. M.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (06) : 395 - 395
  • [36] IDENTIFICATION OF PROGNOSTIC SUBGROUPS BY FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES
    van de Loosdrecht, Arjan
    Canan, Alhan
    Ossenkoppele, Gert
    Westers, Theresia
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 416 - 416
  • [37] Improve or abandon the standardized response criteria for myelodysplastic syndromes recommended by the International Working Group
    Raza, A
    BLOOD, 2001, 98 (01) : 251 - 252
  • [38] Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study
    Della Porta, Matteo G.
    Picone, Cristina
    Pascutto, Cristiana
    Malcovati, Luca
    Tamura, Hideto
    Handa, Hiroshi
    Czader, Magdalena
    Freeman, Sylvie
    Vyas, Paresh
    Porwit, Anna
    Saft, Leonie
    Westers, Theresia M.
    Alhan, Canan
    Cali, Claudia
    van de Loosdrecht, Arjan A.
    Ogata, Kiyoyuki
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08): : 1209 - 1217
  • [39] European LeukemiaNet registry programme for low/INT-1 IPSS score myelodysplastic syndromes
    Bowen, D.
    Droste, J.
    Smith, A.
    Fenaux, P.
    Symeonidis, A.
    Sanz, G.
    Hellstrom-Lindberg, E.
    Cermak, J.
    Gologan, R.
    Germing, U.
    Stauder, R.
    Malcovati, L.
    de Witte, T.
    LEUKEMIA RESEARCH, 2009, 33 : S66 - S67
  • [40] Flow cytometry in myelodysplastic syndromes: Ready for translation into clinical practice
    van de Loosdrecht, Arjan A.
    Westers, Theresia M.
    LEUKEMIA RESEARCH, 2011, 35 (07) : 850 - 852
12345